BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 44 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,606,000 | -38.5% | 2,606,000 | -19.1% | 0.10% | -40.8% |
| Q2 2020 | $4,239,000 | +17.4% | 3,221,000 | -5.5% | 0.17% | -7.9% |
| Q1 2020 | $3,612,000 | -42.5% | 3,407,000 | -41.0% | 0.19% | -23.8% |
| Q4 2019 | $6,280,000 | +5.1% | 5,777,000 | 0.0% | 0.25% | +3.8% |
| Q3 2019 | $5,977,000 | -8.1% | 5,777,000 | 0.0% | 0.24% | -2.4% |
| Q2 2019 | $6,503,000 | -4.4% | 5,777,000 | -3.7% | 0.24% | +4.3% |
| Q1 2019 | $6,799,000 | -14.8% | 5,997,000 | -16.4% | 0.24% | -16.1% |
| Q4 2018 | $7,979,000 | -5.5% | 7,175,000 | +1.8% | 0.28% | +16.7% |
| Q3 2018 | $8,441,000 | – | 7,045,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 4,885,000 | $5,468,000 | 0.79% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 23,153,000 | $25,858,000 | 0.62% |
| RWC Asset Management LLP | 7,300,000 | $8,119,000 | 0.42% |
| IRON Financial LLC | 460,000 | $513,000 | 0.40% |
| Calamos Advisors LLC | 47,578,000 | $53,058,000 | 0.35% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 7,175,000 | $7,979,000 | 0.28% |
| Calamos Wealth Management LLC | 1,370,000 | $1,528,000 | 0.23% |
| SSI INVESTMENT MANAGEMENT LLC | 1,835,000 | $2,043,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,120,000 | $14,628,000 | 0.13% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,221,000 | $3,613,000 | 0.13% |